Antithrombotic therapy in acute coronary syndromes: guidelines translated for the clinician.

Published

Journal Article (Review)

The use of anticoagulant and antiplatelet therapy during the management of acute coronary syndromes (ACS) has been associated with improvements in short- and long-term clinical outcomes, regardless of whether patients are managed conservatively or with acute coronary revascularization. Translating the existing evidence for selection of the most appropriate antithrombotic strategy has been summarized in available guideline recommendations. Given the breadth of antithrombotic recommendations across existing U.S. and European guidelines, synthesis of these recommendations for practicing clinicians who treat patients with ACS are increasingly desired. Providing a summary of the similarities across guidelines while noting the areas where divergence exists becomes an important facet in translating optimal antithrombotic management in ACS for the treating clinician. This review highlights the important aspects of clinical practice guidelines that practicing physicians should consider when selecting antithrombotic therapies to reduce ischemic risk while minimizing hemorrhagic risk across all ACS subtypes.

Full Text

Duke Authors

Cited Authors

  • Gharacholou, SM; Lopes, RD; Washam, JB; Newby, LK; James, SK; Alexander, JH

Published Date

  • May 2010

Published In

Volume / Issue

  • 29 / 4

Start / End Page

  • 516 - 528

PubMed ID

  • 20091089

Pubmed Central ID

  • 20091089

Electronic International Standard Serial Number (EISSN)

  • 1573-742X

Digital Object Identifier (DOI)

  • 10.1007/s11239-009-0437-9

Language

  • eng

Conference Location

  • Netherlands